Treatment of chloroquine-resistant Plasmodium vivax with chloroquine and primaquine or halofantrine.
about
The evolution of tafenoquine--antimalarial for a new millennium?Clinical and parasitological response to oral chloroquine and primaquine in uncomplicated human Plasmodium knowlesi infectionsArtemisinin combination therapy for vivax malariaIn vivo efficacy of artemether-lumefantrine and chloroquine against Plasmodium vivax: a randomized open label trial in central EthiopiaMalaria Distribution, Prevalence, Drug Resistance and Control in IndonesiaVivax malaria: neglected and not benignAtovaquone/proguanil therapy for Plasmodium falciparum and Plasmodium vivax malaria in Indonesians who lack clinical immunity.Therapeutic efficacies of artesunate-sulfadoxine-pyrimethamine and chloroquine-sulfadoxine-pyrimethamine in vivax malaria pilot studies: relationship to Plasmodium vivax dhfr mutations.Therapeutic response of multidrug-resistant Plasmodium falciparum and P. vivax to chloroquine and sulfadoxine-pyrimethamine in southern Papua, Indonesia.Resistance to therapies for infection by Plasmodium vivaxEfficacy of three different regimens of primaquine for the prevention of relapses of Plasmodium vivax malaria in the Amazon Basin of Peru.Confirmed vivax resistance to chloroquine and effectiveness of artemether-lumefantrine for the treatment of vivax malaria in EthiopiaEfficacy and safety of artemisinin combination therapy (ACT) for non-falciparum malaria: a systematic review.High-dose primaquine regimens against relapse of Plasmodium vivax malaria.Therapeutic responses of Plasmodium vivax malaria to chloroquine and primaquine treatment in northeastern MyanmarPyronaridine for treatment of Plasmodium ovale and Plasmodium malariae infections.Plasmodium vivax treatments: what are we looking for?Confirmed Plasmodium vivax Resistance to Chloroquine in Central VietnamResistance of infection by Plasmodium vivax to chloroquine in Bolivia.Chemotherapy of drug-resistant malariaChloroquine resistance in Plasmodium vivax.Failure of Supervised Chloroquine and Primaquine Regimen for the Treatment of Plasmodium vivax in the Peruvian Amazon.World Antimalarial Resistance Network I: clinical efficacy of antimalarial drugs.Effectiveness of combined chloroquine and primaquine treatment in 14 days versus intermittent single dose regimen, in an open, non-randomized, clinical trial, to eliminate Plasmodium vivax in southern Mexico.In vivo therapeutic efficacy of chloroquine alone or in combination with primaquine against vivax malaria in Kolkata, West Bengal, India, and polymorphism in pvmdr1 and pvcrt-o genes.A Randomized Comparison of Chloroquine Versus Dihydroartemisinin-Piperaquine for the Treatment of Plasmodium vivax Infection in Vietnam.Survey of resistance to chloroquine by Plasmodium vivax in Indonesia.Assessment of safety of the major antimalarial drugs.Clinical development of new prophylactic antimalarial drugs after the 5th Amendment to the Declaration of Helsinki.Cytostatic versus cytocidal profiling of quinoline drug combinations via modified fixed-ratio isobologram analysis.A retrospective analysis of the protective efficacy of tafenoquine and mefloquine as prophylactic anti-malarials in non-immune individuals during deployment to a malaria-endemic area.Recent Advances in the Prophylaxis and Treatment of Malaria.Is the malaria diagnosis expensive?The chemotherapy of rodent malaria. LXI. Drug combinations to impede the selection of drug resistance, part 4: the potential role of 8-aminoquinolines.Artemisinin or chloroquine for blood stage Plasmodium vivax malaria in Vietnam.[Role of primaquine in malaria control and elimination in French-speaking Africa].Improved assessment of plasmodium vivax response to antimalarial drugs by a colorimetric double-site plasmodium lactate dehydrogenase antigen capture enzyme-linked immunosorbent assay.Diagnosis and Treatment of Plasmodium vivax Malaria.
P2860
Q24536171-FF067A08-00F2-4D31-B097-3914C69968CFQ24617466-CB3F5CAF-0925-4BF8-9EE5-4DEB1D113010Q24622539-E2E438E5-0319-4BED-80C6-2EEC2AFF338FQ28533253-79CC2F51-6298-46BC-AE67-00DAA7BC3CD6Q29306432-062B6826-935C-4BC9-983F-6F8E72C14F11Q29619167-8B51D9C9-238E-4E11-BC88-9D768ED9A864Q30864028-DD309312-5D36-46E9-91A5-81DDD521613CQ31118886-BC81EEC5-C365-4C84-A244-941C4D760046Q33259717-57340C00-D673-46C4-A759-C6F14056DD72Q33481576-E6C2C848-F2A0-486C-A492-D2E866F1ACA3Q33841091-8F939CA6-1845-4D25-9168-F9EAD0235796Q34422288-73D8E51F-C5F0-4841-A67A-AD29E1E9D5E6Q34646141-EBAEF9BA-EB77-4E80-86C5-697A5C7583A7Q35086211-DD2DDBC1-CB67-477A-9375-3263A3D32024Q35105826-D306CD64-7816-46F2-A195-DC5BD70A19EBQ35138701-62D3C98F-213F-4E81-B8C9-65469CFDCF05Q35760893-04653B5B-CBD7-4AEF-8778-5FE6B3E6B2C2Q35782842-FAD5709A-B511-4EEB-9427-7A1E1E94B5D9Q35806973-AFE59749-6159-4127-A7B7-FDBFD4EF60C5Q35891386-3D567339-3007-4834-BC25-D59565F9F2D9Q35927662-0843EA73-4B9D-4526-8E50-E0ED83F2F996Q36020650-E619C598-77F0-4744-81F7-5FC02E2AB20AQ36037701-CDA0EBC6-A26D-4117-A686-89FD9327666AQ36235143-973BED07-3887-46EC-8E02-8A3C12FF723EQ36667032-14DAD060-4B04-4CB4-B864-6CDD553C4C17Q36776130-C491B9BC-8CCD-4656-A180-8EC3D52BB23EQ36828336-E913FD9C-4DF1-494A-A3CD-A9438C7DE9F4Q36945007-6BCC0622-53BF-47E7-9DA1-202494048AACQ37052790-4B770D86-72E5-4A35-AC8E-632545C92F81Q37418342-A1D0FC4A-6C04-4110-8945-97E92E43E56BQ37617688-772680E4-1A43-40C9-A00E-847E0F3C66F0Q39155334-C7B916D4-447A-4E74-AD34-64C28F42BF90Q39348243-D94500B8-5D3B-4AFA-9AD4-6A226C221E55Q39351649-E271339E-B954-4E49-9359-02D9EF4D8C68Q39353584-0ADFFDED-9236-4B71-AE09-E80CD2002616Q40247802-EB1C98AB-8D6C-4C8A-AEB4-1012DCC2F248Q41943311-0A723F88-8C06-41A9-B1F9-BCF763B1A94FQ53767337-7855451A-6C28-4B9C-AD8F-6553A28C6199
P2860
Treatment of chloroquine-resistant Plasmodium vivax with chloroquine and primaquine or halofantrine.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Treatment of chloroquine-resis ...... nd primaquine or halofantrine.
@ast
Treatment of chloroquine-resis ...... nd primaquine or halofantrine.
@en
type
label
Treatment of chloroquine-resis ...... nd primaquine or halofantrine.
@ast
Treatment of chloroquine-resis ...... nd primaquine or halofantrine.
@en
prefLabel
Treatment of chloroquine-resis ...... nd primaquine or halofantrine.
@ast
Treatment of chloroquine-resis ...... nd primaquine or halofantrine.
@en
P2093
P356
P1476
Treatment of chloroquine-resis ...... nd primaquine or halofantrine.
@en
P2093
Fryauff DJ
McElroy PD
Subianto B
Wignall FS
P304
P356
10.1093/INFDIS/171.6.1678
P407
P577
1995-06-01T00:00:00Z